Recent insights into the biological activities and drug delivery systems of tanshinones

被引:87
作者
Cai, Yuee [1 ]
Zhang, Wenji [2 ,3 ]
Chen, Zirong [4 ]
Shi, Zhi [1 ,2 ,3 ]
He, Chengwei [1 ]
Chen, Meiwan [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China
[2] Jinan Univ, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China
[3] Jinan Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med,Inst Biomed, Guangzhou, Guangdong, Peoples R China
[4] Univ Florida, Shands Canc Ctr, Dept Mol Genet & Microbiol, Gainesville, FL USA
基金
中国国家自然科学基金;
关键词
tanshinones; biological activities; drug delivery systems; bioavailability; solubility; SALVIA-MILTIORRHIZA BUNGE; PROSTATE-CANCER CELLS; SOLID LIPID NANOPARTICLES; MAJOR ACTIVE CONSTITUENT; KAPPA-B ACTIVATION; IN-VITRO; II-A; OSTEOCLAST DIFFERENTIATION; INTESTINAL-ABSORPTION; CEREBRAL-ISCHEMIA;
D O I
10.2147/IJN.S84035
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Tanshinones, the major lipid-soluble pharmacological constituents of the Chinese medicinal herb Tanshen (Salvia miltiorrhiza), have attracted growing scientific attention because of the prospective biomedical applications of these compounds. Numerous pharmacological activities, including anti-inflammatory, anticancer, and cardio-cerebrovascular protection activities, are exhibited by the three primary bioactive constituents among the tanshinones, ie, tanshinone I (TNI), tanshinone IIA (TNIIA), and cryptotanshinone (CPT). However, due to their poor solubility and low dissolution rate, the clinical applications of TNI, TNIIA, and CPT are limited. To solve these problems, many studies have focused on loading tanshinones into liposomes, nanoparticles, microemulsions, cyclodextrin inclusions, solid dispersions, and so on. In this review, we aim to offer an updated summary of the biological activities and drug delivery systems of tanshinones to provide a reference for these constituents in clinical applications.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 116 条
[1]   Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions [J].
Adams J.D. ;
Wang R. ;
Yang J. ;
Lien E.J. .
Chinese Medicine, 1 (1)
[2]   Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells [J].
Cao, EH ;
Liu, XQ ;
Wang, JJ ;
Xu, NF .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (06) :801-806
[3]   Preparation, Characterization and Cytotoxicity Evaluation of Tanshinone IIA Nanoemulsions [J].
Chang, Li-Ching ;
Wu, Chi-Lien ;
Liu, Ching-Wen ;
Chuo, Wen-Ho ;
Li, Ping-Chia ;
Tsai, Tong-Rong .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2011, 7 (04) :558-567
[4]   Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress [J].
Chen, Wenying ;
Tang, Futian ;
Xie, Bailu ;
Chen, Shaorui ;
Huang, Heqing ;
Liu, Peiqing .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 674 (2-3) :359-364
[5]   Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrier [J].
Chen, X. ;
Zhou, Z.-W. ;
Xue, C. C. ;
Li, X. X. ;
Zhou, S.-F. .
XENOBIOTICA, 2007, 37 (06) :635-678
[6]   Cardiovascular effects of Danshen [J].
Cheng, Tsung O. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 121 (01) :9-22
[7]   Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo [J].
Chiu, S. C. ;
Huang, S. Y. ;
Chen, S. P. ;
Su, C. C. ;
Chiu, T. L. ;
Pang, C. Y. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) :315-322
[8]   Nanoparticles and the environment - Introduction [J].
Chow, JC ;
Biswas, P ;
Eatough, D ;
McDade, C ;
Mueller, P ;
Overcamp, T ;
Watson, J ;
Wu, CY .
JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION, 2005, 55 (06) :706-707
[9]   Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro [J].
Chu, Ting ;
Zhang, Qing ;
Li, Hui ;
Ma, Wei-cong ;
Zhang, Na ;
Jin, Hui ;
Mao, Sheng-jun .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 424 (1-2) :76-88
[10]  
ElBayoumi TA, 2010, METHODS MOL BIOL, V605, P1, DOI 10.1007/978-1-60327-360-2_1